NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 21, 2026 — Spivi and Les Mills announce strategic partnership bringing Les Mills cycling programs to Spivi's gamification platform, revolutionizing group fitness with immersive technology and proven content.
April 21, 2026 — Phi Earth Technologies and Sana Fortis partner on biomass pilot in Singapore and Malaysia, combining Phi Trees™ with HTG Grass for sustainable energy and agroforestry solutions.
April 21, 2026 — BioXgen announces a Regulation Crowdfunding investment offering and live webinar for its cardiac patch to prevent post-operative atrial fibrillation after open-heart surgery.
April 20, 2026 — Supply Veins returns to eMerge Americas 2026 with AI procurement platform for manufacturers & defense. Veteran-led company transforms supply chain communication into structured data for resilience.
April 20, 2026 — Schaeffler wins Hermes Award for humanoid robot actuator platform that reduces costs by 50%. Innovative design cuts size/weight while enabling industrial-scale production.
April 20, 2026 — Schaeffler wins prestigious Hermes Award for innovative actuator platform designed for humanoid robot joints, addressing 50% of robot costs to enable industrial scalability.
April 20, 2026 — Formycon AG announces 2025 financial results release on April 22, 2026, with live webcast and investor conferences. Learn about biosimilars and company outlook.
April 20, 2026 — Safe Pro Group repurchases 400,000 shares while investing in AI defense technology. The company's drone imagery processing platform enhances security and operational efficiency globally.
April 20, 2026 — LIXTE Biotechnology's LB-100 cancer drug enhances chemotherapy effectiveness through PP2A inhibition. Clinical trials show promise for ovarian, colon cancers & sarcoma treatment improvements.
April 20, 2026 — Soligenix receives European Commission orphan drug designation for SGX945 targeting Behçet's disease, marking a key regulatory milestone for rare disease treatment development.
April 20, 2026 — MindBio Therapeutics launches Intox Collect™ AI tool for detecting multiple drugs & alcohol through voice/facial recognition. Targets mining, aviation & construction safety with 50M+ data points.
April 20, 2026 — Massimo Group (NASDAQ: MAMO) appoints Quenton Petersen as CEO, with David Shan becoming Executive Chairman. The company plans growth in utility vehicles and electric mobility, exploring AI and smart mobility tech.
April 20, 2026 — Genius Group closes $8M direct offering to expand AI education platform serving 6M users globally. Learn how this funding supports personalized learning pathways.
April 20, 2026 — Soligenix CEO advocates for patient-centric drug development, highlighting reformulation of SGX945 from IV to subcutaneous to improve access and adherence in rare disease treatment.
April 20, 2026 — Enhanced Group plans public debut via SPAC merger with A Paradise Acquisition Corp., targeting sports, media, and consumer health growth amid 2025 investment shifts, per Channelchek report.
April 20, 2026 — Wearable Devices partners with Meta-Bounds to integrate neural wristband technology with AR hardware, enabling touchless spatial interaction for enhanced user experiences in gaming and enterprise applications.
April 20, 2026 — Oragenics advances Phase IIa trial for ONP-002, a first-in-class intranasal treatment for concussion. Two patients enrolled in Australia trial addressing unmet need for FDA-approved mTBI therapies.
April 20, 2026 — Brean Capital initiates Buy rating for OptimumBank Holdings with $8 price target. Florida-based community bank gains research coverage highlighting growth strategy and business model performance.
April 20, 2026 — Beeline Holdings partners with SRG to embed mortgage and title services into AI-driven real estate platforms, targeting 2,000 home financings and streamlining the path to homeownership.
April 20, 2026 — BioMedWire highlights Oncotelic Therapeutics as biotech shifts to valuing science as financial assets. Learn how pipeline progress now impacts balance sheets and investor strategies in oncology innovation.